Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 USD | -1.29% |
|
-3.96% | -25.37% |
06-05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.37% | 198M | |
+32.02% | 460B | |
+39.04% | 295B | |
+14.15% | 147B | |
+8.79% | 93.51B | |
+27.22% | 90.6B | |
+67.79% | 61.46B | |
+11.99% | 46.17B | |
+21.32% | 36.97B | |
+18.60% | 30.21B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Appoints Edward Stelmakh as Chief Financial Officer